Skip to content

908 Devices MASS Contingent Consideration Liability (Non-Current)

Contingent Consideration Liability (Non-Current) at other companies

Abbott logo
AbbottABT
$1M-97.4%
Idexx Laboratories logo
Idexx LaboratoriesIDXX

Other financials

Income statement

See full
Revenue$13.4M+13.6%
Gross profit$6.9M+24.2%
Operating income-$12.9M-16.9%
Net income-$12.0M-127%
EPS (diluted)-$0.32-126%

Balance sheet

See full
Cash & equivalents$67.6M-14.7%
Total debt$4.5M+18.6%
Total equity$134.2M-15.8%
Total assets$186.7M-4.8%

Cash flow

See full
Operating cash flow$1.2M+108%
CapEx$40.0K-74.8%
Free cash flow$1.2M+108%

Valuation

See full
Market cap$339.57M+29.0%
Enterprise value$276.47M+47.2%
P/S5.9×+0.8×

Profitability

See full
Gross margin51.5%+1.3pp
Operating margin-76.8%-19.6pp
Net margin-62.4%+323pp
FCF margin-16.7%-7.2pp

Returns & leverage

See full
Return on equity-24.6%-149pp
Debt / equity0.0×
Current ratio3.6×-4.0×

Where this comes from

Reported directly by 908 Devices in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent.

The official record: 908 Devices’s 10-K, filed March 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about 908 Devices's contingent consideration liability (non-current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is 908 Devices's contingent consideration liability (non-current)?
908 Devices (MASS) reported contingent consideration liability (non-current) of $2.28M in Q4 2024.
What does contingent consideration liability (non-current) mean?
This liability represents the estimated fair value of future payments owed to sellers following a business acquisition, contingent upon the achievement of specific performance milestones or financial targets. It reflects long-term financial obligations tied to inorganic growth strategies and the successful integration of acquired assets. Investors track this to understand potential future cash outflows and the risks associated with the company's M&A strategy.